Collectively, these investigations suggested the plausibility of modulating the rate of drug release as well as specifically targeting different GSTs by modifying the sulfonamide moiety 128
Because such quality is the foundation for noticeable and sustainable treatment success
doi: 10.1073/pnas.1701482114 7 BosnjakZ.YanY.CanfieldS.MuravyevaM.KikuchiC.WellsC.et al
Use of stomach acid-resistant capsules (DRcaps ) further protect stability
Reversal of gene expression correlates with drug efficacy and reveals therapeutic targets
Nuytemans K, Theuns J, Cruts M, van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update